Stockreport
Amgen Touts Broad Portfolio Momentum, MariTide Milestones and Repatha Access Push at TD Cowen Conf [Yahoo! Finance]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Amgen (NASDAQ:AMGN) executives highlighted broad-based commercial momentum, a focus on long-term growth drivers, and several upcoming pipeline milestones during a fireside chat at the 46th Annual TD Cowen Healthcare Conference. Portfolio momentum and growth drivers Amgen said it exited 2025 with “strong momentum across the portfolio,” reporting that 13 products delivered double-digit growth, 14 products exceeded $1 billion in annual sales, and 18 delivered record performance. Management said this breadth supported double-digit growth in both revenue and earnings per share in 2025. ? The Head Fake: Buying the Chinese Stocks Post-Ruling Dip 3 Healthcare Giants Just Raised Dividends—Here's Who Pays the Most Executives pointed to six key growth drivers: Repatha EVENITY TEZSPIRE , and the company's rare disease innovative oncology , and biosimilars portfolios. Repatha, EVENITY, and TEZSPIRE each grew more than 30% year-over-year in 2025 and delivered record sales, which Amgen ch
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Amgen (AMGN) had its "market perform" rating reaffirmed by Leerink Partners.[MarketBeat]
- AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE[PR Newswire]
- Amgen: Wait For A Better Entry Point (Rating Downgrade) [Seeking Alpha][Seeking Alpha]
- Amgen declares $2.52 dividend [Seeking Alpha][Seeking Alpha]
- AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND[PR Newswire]
- More
AMGN
SEC Filings
SEC Filings
- 3/2/26 - Form 4
- 2/27/26 - Form 144
- 2/24/26 - Form 25-NSE
- AMGN's page on the SEC website
- More